The purpose of this test is to evaluate the sensitizing potential of a personal lubricant, as a result of repeated occlusive patch. The intervention will be applied for a total of 9 induction applications, followed by an approximately 2 week rest period, then followed by a 24-72 hour Challenge applications.

Inclusion Criteria:

• good health as determined from screener
• signed and dated informed consent
• signed and dated HIPAA Form

Exclusion Criteria:

• subjects on test at any other research laboratory or clinic
• known allergy or sensitivity to cosmetics and toiletries, including sunscreens, adhesives and/or topical drugs
• pre-existing dermatologic conditions which have been diagnosed by a medical professional (e.g. psoriasis, eczema, etc.) which would interfere with this study
• pre-existing other medical conditions (e.g. adult asthma, diabetes).
• treatment with antibiotics, antihistamines or corticosteroids within two weeks prior to initiation of the test
• chronic medication which could affect the results of the study (e.g., insulin, corticosteroids, antihistimines, steroidal or non-steroidal anti-inflammatory drugs [except for therapeutic maintenance dosage of aspirin], antibiotics, steroid inhalers, etc.)
• known pregnant or nursing women

All participants receive the same interventions